Share |
  • Eucomed represents the medical technology industry in Europe
  • www.ethicalmedtech.eu - The new portal featuring the first MedTech event clearance system
  • Medical technology enables people to live healthy and productive lives
  • We support safe, smart and sustainable medical technology legislation in Europe
  • Our mission is to make modern, innovative and reliable medical technology available to more people
  • Our industry's continuous vital innovations improve people's lives

You better watch out!

Yesterday, we, at Eucomed, had our Christmas party (Happy Christmas everybody and a big thank you to all the Eucomed members and staff for everything in 2010!!). And while thinking back at yesterday's little get-together, it’s dawning on me that with 2011 just around the corner we will be just over two and half years since the original public consultation on the recast of the EU medical devices legislation.

Has much happened in the meantime?  Well everything and nothing really.

At the Eucomed level and EU level we had: Positioning; Engagement, Postponement, Exploratory Process, European Parliament Elections, New Commission, responsibilities for Medical Devices moves from industry to health at the Commission level (DG SANCO), Re-engagement with new European Parliament and Commission, meetings with the new Health Commissioner, John Dalli, further meetings with the new Chief of DG SANCO, Paolo Testori Coggi and her staff at DG SANCO, Medtech Forum Innovation Union and (ever so slightly) revised Commission Roadmap.

But for all of this, there is still no publicly available text. Not even an early draft. So in a sense, there is nothing.

So “Is there really a recast?” you may ask. It’s the same question as “Is there really a Santa Claus?”. And both have the same answer: Yes (just in case my kids are reading this).

And this ‘yes’ will really be apparent next year. Already 2011 looks like this: Eucomed/AdvaMed Joint Meeting on Recast (Washington, Jan 11 & 12 – do come), Eucomed/Commission high level workshop on Recast, EU High Level Conference on Innovation and Recast, Impact Assessment on Recast, Draft Texts, Targeted Consultations, MEP briefings, Medtech Forum, Meetings with Commissioners etc. etc.

Busy times.  But with the continued support of a wonderful membership and Board, and working together with the whole Brussels stakeholder group – patients, healthcare professionals other associations and the institutions – it should be engaging, worthwhile, effective and, last but not least, FUN!

You better watch out! Better not cry! Better not pout!  I'm telling you why, The Recast is comin' to town… Happy Christmas

John Brennan
Director Regulatory and Technical Affairs

blog comments powered by Disqus